slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 86,611-86,640
Pages 3,225
Rows per page 30
Component
86,611-86,640 of 96,741
36
Limoneira | Investor Presentation Deck | 39 slidesLimoneira | Investor Presentation Deck | 39 slides · Limoneira
Pitch deck Investor relations Beat · Impact & Next Steps1 hit
09
The slide uses a process-like flow to connect six distinct megatrends to the company's strategic focus.Lindsay Corporation | Results Presentation Deck | 17 slides · Lindsay Corporation
Conference presentation Investor relations Beat · SatisfactionLoop · Logic Chain1 hit
20
Data is YTD as of 9/30/22.MainStreet Bancshares | Results Presentation Deck | 31 slides · MainStreet Bancshares, Inc.
Conference presentation Investor relations Beat · Satisfaction1 hit
06
The slide uses a comparative structure to explain two distinct biological pathways for drug delivery.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
11
The diagram uses a hub-and-spoke model to define the 'ideal' product profile.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
16
The chart uses a vertical dotted line at 0.2 to denote a clinical efficacy threshold.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Beat · Traction1 hit
20
Clinical trial design diagram showing randomization into three arms with specific drug regimens over a 10-week period.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations Loop · Quick Win Big Bet1 hit
25
The slide highlights clinical safety and pharmacokinetic success for an oral formulation of amikacin.Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
28
The slide emphasizes long-term exclusivity through both patent filings and regulatory status (QIDP/ODD).Matinas BioPharma | Investor Presentation Deck | 31 slides · Matinas BioPharma
Pitch deck Investor relations 1 hit
05
Includes details on upfront payments, private placement, and milestone/royalty structures.NeuroBo Pharmaceuticals | Securities Offering Presentation Deck | 30 slides · NeuroBo Pharmaceuticals
Regulatory filing Investor relations 1 hit
01
Nuvalent | Investor Presentation Deck | 31 slidesNuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations 1 hit
06
The slide uses a human anatomy diagram to map specific TRK receptor inhibition (TRKB, TRKC, TRKA) to associated clinical side effects.Nuvalent | Investor Presentation Deck | 31 slides · Nuvalent
Conference presentation Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
12
The charts are flow cytometry histograms showing CFSE dilution, a standard assay for cell proliferation.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
14
Includes longitudinal patient data and representative imaging.Organicell Regenerative Medicine | Investor Presentation Deck | 17 slides · Organicell Regenerative Medicine
Pitch deck Investor relations 1 hit
12
The chart uses a combination of bar (absolute $) and line (percentage) to show trends.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
14
The chart combines a bar chart for active customers and a line chart for order frequency.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
15
The chart displays a decline in order volume alongside an increase in average order value.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Satisfaction1 hit
24
The central logo acts as the hub for the strategic initiatives.Overstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
25
Overstock | Results Presentation Deck | 34 slidesOverstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
30
Overstock | Results Presentation Deck | 34 slidesOverstock | Results Presentation Deck | 34 slides · Overstock
Conference presentation Investor relations Beat · Action1 hit
11
The slide highlights the strategic importance of the first US approval for Suramin.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
13
The slide uses a background map of the world to emphasize the global nature of the condition, despite the specific US prevalence statistic.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · ProblemLoop · Cost Of Inaction1 hit
14
The slide uses a biological process diagram to explain the drug's mechanism.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide displays two line charts comparing PAX-101 against placebo across multiple time points, with error bars indicating standard error.PaxMedica | Investor Presentation Deck | 24 slides · PaxMedica
Pitch deck Investor relations 1 hit
08
The slide uses a combination of stacked bar charts for audience metrics and grouped bar charts for financial metrics to demonstrate the accretive nature of the acquisition.Playstudios | Mergers and Acquisitions Presentation Deck | 11 slides · Playstudios
Deck Investment bank 1 hit
27
The slide uses a vertical hierarchy to distinguish between 'Oversight' (Board) and 'Execution' (Management) functions.Regions Financial Corporation | Results Presentation Deck | 38 slides · Regions
Conference presentation Investor relations Beat · Action1 hit
05
Includes footnotes regarding non-GAAP measures and specific merger-related charges.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Situation & Context1 hit
11
The slide uses a table to show the impact of interest rate changes on NII, with specific assumptions listed for each period.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
12
The slide includes a callout box explaining the basis of the outlook (rate changes implied by 10/17/22 forward curve).Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Problem & ComplicationLoop · Cost Of Inaction1 hit
15
The chart uses a combination of stacked bars for absolute values and line graphs for growth percentages, with shaded regions highlighting historical market events.Silicon Valley Bank | Results Presentation Deck | 52 slides · SVB
Conference presentation Investor relations Beat · Solution & Approach1 hit